Extended Follow-Up Confirms Efficacy of First-Line Pembrolizumab Plus Lenvatinib in Advanced Non–Clear Cell RCC.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 60
- By:
- Publication type:
- Article
Works matching IS 23745347 AND DT 2024 AND VI 25 AND IP 5
Results: 13
1
2
Adjuvant Pembrolizumab Improves DFS but Not OS in Locally Advanced/Muscle-Invasive Urothelial Carcinoma.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 58
- By:
- Publication type:
- Article
3
Atezolizumab Plus Cabozantinib Improves PFS Over Novel Hormonal Therapy in mCRPC.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 50
- By:
- Publication type:
- Article
4
Segmenting the Utility of ADCs in NSCLC: How These Agents Are Affecting Second-Line Standards.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 46
- By:
- Publication type:
- Article
5
Immune Checkpoint Inhibitors Revolutionize Endometrial Cancer Treatment.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 40
- By:
- Publication type:
- Article
6
Patient Insurance Status and Out-of-Pocket Costs Affect Genomic Testing Frequency.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 42
- By:
- Publication type:
- Article
7
ONC201 Looks to Prove Efficacy in Trial for Rare H3K27M-Mutated Diffuse Midline Gliomas.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 34
- By:
- Publication type:
- Article
8
All Eyes Are on IL-15 in Early-Phase Studies.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 31
- By:
- Publication type:
- Article
9
Despite FDA’s Call for Secondary Malignancies Boxed Warning on CAR T-Cell Agents, Questions Linger.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 24
- By:
- Publication type:
- Article
10
NALIRIFOX Approval Adds to the Therapeutic Arsenal for Pancreatic Cancer Management.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 14
- By:
- Publication type:
- Article
11
ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 16
- By:
- Publication type:
- Article
12
Is It Time to Address the Fiscal Reality of the Cancer Care Model and Consider Alternatives?
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 10
- By:
- Publication type:
- Article
13
Checking the Pulse on the Next Wave of Advancements.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 8
- By:
- Publication type:
- Article